Is a complete FRA/DB0 research report available?

No complete published report is available for fra/DB0 (FRA/DB0) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/DB0 (FRA/DB0)

Frankfurt Stock Exchange: FRA/DB0 · EUR

—

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-03 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/DB0 analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	405.7M
Revenue (ttm)	46.6M
Net income (ttm)	28.8M
EPS (ttm)	€2.25
P/E (trailing)	14.1x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 46.6M
Net income (ttm): 28.8M
EPS (ttm): €2.25
P/E (trailing): 14.1x
Market cap: 405.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

All FRA/DB0 indicators

Market & fundamental data

Available fields

150

Groups with data

Currency

USD

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	22
Employees Change	-7%
Employees Change Percent	-24.14
Enterprise value	EUR 373.4M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-08-03
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-08-03
Market cap	EUR 405.7M
Price currency	EUR
Rev Per Employee	2,118,459.09x
Sic	2836
Symbol	fra/DB0
Website	https://www.q32bio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.11%
EV Earnings	12.95x
EV/EBIT	20.07x
EV/EBITDA	18.34x
EV/Sales	7.99x
FCF yield	-5.86%
P/B ratio	10.1x
P/E ratio	14.07x
P/S ratio	8.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	39.84%
EBITDA Margin	40.51%
Gross margin	71.62%
Gross Profit	EUR 33.4M
Net Income	EUR 28.8M
Pretax Margin	61.86%
Profit Margin	61.86%
Profit Per Employee	EUR 1.3M
ROA	18.75
ROCE	40.39
ROE	157.2
ROIC	35.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	627.66%
Cagr3y	-3.35%
Cagr5y	-34%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.75
Assets	EUR 55.2M
Cash	EUR 44M
Current Assets	EUR 49.6M
Current Liabilities	EUR 9.2M
Debt	EUR 11.8M
Debt EBITDA	EUR 0.58
Debt Equity	EUR 0.29
Debt FCF	EUR -0.5
Equity	EUR 40.2M
Interest Coverage	21.41
Liabilities	EUR 15.1M
Long Term Assets	EUR 5.6M
Long Term Liabilities	EUR 5.8M
Net Cash	EUR 32.2M
Net Cash By Market Cap	EUR 7.93
Net Cash Growth	-20.52%
Net Debt EBITDA	EUR -1.7
Net Debt Equity	EUR -0.8
Tangible Book Value	EUR 40.2M
Tangible Book Value Per Share	EUR 2.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.36
Net Working Capital	EUR 2.4M
Quick ratio	4.81
Working Capital	EUR 40.4M
Working Capital Turnover	EUR 0.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	626.67%
200-day SMA	5.52
3Y total return	-9.73%
50-day SMA	11.33
50-day SMA vs 200-day SMA	50over200
5Y total return	-87.47%
All Time High	484.7
All Time High Change	-97.3%
All Time High Date	2019-04-08
All Time Low	1.1
All Time Low Change	1,089.09%
All Time Low Date	2025-07-08
ATR	0.88
Ch YTD	399.2
High52	17
High52 Date	2026-07-14
Low52	1.35
Low52 Date	2025-08-11
Ma50ch	15.45%
Price vs 200-day SMA	137.09%
RSI	53.11
RSI Monthly	44.37
RSI Weekly	69.53
Sharpe ratio	1.59x
Sortino ratio	4.63
Total Return	-5.51%
Tr YTD	399.2
Tr1m	4.22%
Tr1w	-7.56%
Tr3m	185.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 18.6M
Operating margin	39.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,469,159%
Net Borrowing	-4,063,624
Shares Insiders	0.58%
Shares Institutions	20.51%
Shares Qo Q	11.93%
Shares Yo Y	5.51%
Short Ratio	1.51

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -28.5M
Adjusted OCF	-28,487,842.1
Average Volume	90.05x
Bv Per Share	2.75
Ch1m	4.22
Ch1w	-7.56
Ch1y	626.7
Ch3m	185.1
Ch3y	-9.73
Ch5y	-87.47
Ch6m	303.7
Depreciation Amortization	313,786.7
Earnings Date	2026-08-06
EBIT	EUR 18.6M
EBITDA	EUR 18.9M
EPS	EUR 2.25
F Score	4
FCF	EUR -23.8M
FCF EV Yield	-6.36x
Financing CF	4,919,326
Fiscal Year End	December
Founded	2,017
Graham Number	5.20431
Graham Upside	-60.21
Investing CF	6,071,100
Is Primary Listing	0
Last Report Date	2026-03-31
Last Split Date	2024-03-26
Last Split Type	Reverse
Ma150	6.57
Ma150ch	99.24%
Ma20	13.03
Ma20ch	0.37%
Net CF	-12,777,064
Next Earnings Date	2026-08-06
Ppne	5,050,058.4
Price EBITDA	EUR 21.49
Ptbv Ratio	10.1
Revenue	46,606,100x
SBC By Revenue	10.16x
Share Based Comp	4,736,325
Tr6m	303.7%
Z Score	-0.61

FRA/DB0 (FRA/DB0)

Coverage state: Market snapshot only — no published research

Generate the first FRA/DB0 analysis

Price

Financial snapshot

Latest news · FRA/DB0

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All FRA/DB0 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/DB0

Frequently asked questions